Long-term follow-up of multivessel percutaneous coronary intervention with drug-eluting stents for de novo lesions with correlation to the SYNTAX score

被引:10
|
作者
Gerber, Robert T. [1 ,2 ]
Ielasi, Alfonso [1 ]
Al-Lamee, Rasha [1 ,2 ]
Latib, Azeem [1 ,2 ]
Airoldi, Flavio [1 ]
Ferraro, Massimo [2 ]
Ferri, Luca [1 ]
Bassanelli, Giorgio [1 ]
Godino, Cosmo [1 ,2 ]
Sharp, Andrew S. P. [1 ,2 ]
Chieffo, Alaide [1 ]
Carlino, Mauro [1 ]
Montorfano, Matteo [1 ]
Sangiorgi, Giuseppe M. [1 ,2 ]
Colombo, Antonio [1 ,2 ]
机构
[1] Osped San Raffaele, Catheterisat Lab, I-20132 Milan, Italy
[2] EMO GVM Ctr Cuore Columbus, I-20145 Milan, Italy
关键词
Drug eluting stents; Restenosis; Stent thrombosis; Revascularisation;
D O I
10.1016/j.carrev.2010.10.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Stent thrombosis (ST) and restenosis are concerns after percutaneous coronary intervention (PCI). Limited information exists concerning clinical and angiographic outcomes following multiple stent insertion. We therefore present the long-term outcome from drug-eluting stent (DES) insertion and correlate this with the Syntax score. Methods and Results: Between April 2002 and 2006, all patients that underwent multilesion PCI (defined as >= 4 DES) were included for analysis, and follow-up commenced from the point where the fourth stent was inserted. Three hundred and seventy-four patients were identified, comprising 1972 lesions; 99% had clinical (30 +/- 16 months), and 72% had angiographic follow-up. The mean number of stents implanted was 5.7 +/- 1.9 and with length of 137 +/- 50 mm and Syntax Score of 24 +/- 8. The Syntax score (SS) did not predict major adverse cardiac events (MACE) at long-term follow-up, which occurred in 33% in the low SS (<22), 34% intermediate SS (22-32) and 40% in the high SS (>33); P=ns. However, the number of stents implanted correlated with events [MACE: 12% (4 DES), 35% (4-6 DES), 61% (>6 DES)]. There were 11 (2.9%) definite and probable ST: four acute and subacute, three late, and four very late. Conclusions: This study demonstrates an acceptable occurrence of myocardial infarction, death, repeat revascularisation, and ST in patients with multivessel de novo lesions, which had better correlation with the number of DES inserted than the Syntax score. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:220 / 227
页数:8
相关论文
共 50 条
  • [1] Long-term follow-up of percutaneous coronary intervention of unprotected left main lesions with drug eluting stents: predictors of clinical outcome
    Pavei, Andrea
    Oreglia, Jacopo A.
    Martin, Guillaume
    Tousek, Petr
    Sharif, Faisal
    Farah, Bruno
    Sauguet, Antoine
    Fajadet, Jean
    EUROINTERVENTION, 2009, 4 (04) : 457 - 463
  • [2] Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents
    Rossini, Roberta
    Musumeci, Giuseppe
    Aprile, Alessandro
    Valsecchi, Orazio
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2010, 10 (01) : 49 - 61
  • [3] Long-term efficacy of drug coated balloons compared with new generation drug-eluting stents for the treatment of de novo coronary artery lesions
    Venetsanos, Dimitrios
    Lawesson, Sofia Sederholm
    Panayi, Georgios
    Todt, Tim
    Berglund, Ulf
    Swahn, Eva
    Alfredsson, Joakim
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 92 (05) : E317 - E326
  • [4] Impact of Chronic Kidney Disease on the Efficacy of Drug-Eluting Stents: Long-term Follow-up Study
    Gomes, Vitor Osorio
    Blaya, Patricia
    Lasevitch, Ricardo
    Oliveira, Denise
    Hickmann, Patricia
    Smidt, Luis
    Polanczyk, Carisi
    Caramori, Paulo
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2011, 96 (05) : 346 - 351
  • [5] Clinical outcome after percutaneous treatment of de novo coronary bifurcation lesions using first or second generation of drug-eluting stents
    Miroslaw Ferenc
    Heinz Joachim Buettner
    Michael Gick
    Thomas Comberg
    Juergen Rothe
    Firas Khoury
    Christian Valina
    Aurel Toma
    Piotr Kuebler
    Florian Riede
    Franz-Josef Neumann
    Clinical Research in Cardiology, 2016, 105 : 230 - 238
  • [6] Clinical outcome after percutaneous treatment of de novo coronary bifurcation lesions using first or second generation of drug-eluting stents
    Ferenc, Miroslaw
    Buettner, Heinz Joachim
    Gick, Michael
    Comberg, Thomas
    Rothe, Juergen
    Khoury, Firas
    Valina, Christian
    Toma, Aurel
    Kuebler, Piotr
    Riede, Florian
    Neumann, Franz-Josef
    CLINICAL RESEARCH IN CARDIOLOGY, 2016, 105 (03) : 230 - 238
  • [7] Long-term follow-up results in patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents: results from a single high-volume PCI centre
    Yao, Hai-Mu
    Wan, You-Dong
    Zhang, Xiao-Juan
    Shen, De-Liang
    Zhang, Jin-Ying
    Li, Ling
    Zhao, Luo-Sha
    Sun, Tong-Wen
    BMJ OPEN, 2014, 4 (08):
  • [8] Are All New-Generation Drug-Eluting Stents Equal? - Long-Term Follow-up Is Necessary -
    Tanabe, Kengo
    CIRCULATION JOURNAL, 2018, 82 (06) : 1497 - 1498
  • [9] Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents
    Matteau, Alexis
    Yeh, Robert W.
    Camenzind, Edoardo
    Steg, Gabriel P.
    Wijns, William
    Mills, Joseph
    Gershlick, Anthony
    de Belder, Mark
    Ducrocq, Gregory
    Mauri, Laura
    CIRCULATION, 2013, 128 (22)
  • [10] Outcomes After Percutaneous Coronary Intervention of Ostial Lesions in the Era of Drug-Eluting Stents
    Freeman, Melanie
    Clark, David J.
    Andrianopoulos, Nick
    Duffy, Stephen J.
    Lim, Han S.
    Brennan, Angela
    Charter, Kerrie
    Shaw, James
    Horrigan, Mark
    Ajani, Andrew E.
    Sebastian, Martin
    Reid, Christopher M.
    Farouque, H. M. Omar
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2009, 73 (06) : 763 - 768